Sangamo Therapeutics Ownership | Who Owns Sangamo Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Sangamo Therapeutics Ownership Summary

Sangamo Therapeutics is owned by 27.04% institutional investors, 2.38% insiders, and 70.58% retail investors. Vanguard group is the largest institutional shareholder, holding 4.50% of SGMO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.81% of its assets in Sangamo Therapeutics shares.

SGMO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sangamo Therapeutics	27.04%	2.38%	70.58%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	9.37M	4.50%	$9.56M
Wasatch advisors lp	9.23M	4.43%	$9.42M
Blackrock	4.70M	2.61%	$1.69M
Blackrock funding, inc. /de	5.19M	2.49%	$5.30M
Jacobs levy equity management	2.95M	1.64%	$1.06M
Renaissance	3.08M	1.48%	$3.15M
Millennium management	2.74M	1.31%	$2.79M
Point72 asset management	2.27M	1.09%	$2.32M
Geode capital management	2.21M	1.06%	$2.26M
Ikarian capital	1.86M	0.89%	$1.90M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Acuta capital partners	740.00K	0.76%	$754.80M
Ikarian capital	1.86M	0.26%	$1.90M
Golden state equity partners	325.68K	0.06%	$332.20K
Wasatch advisors lp	9.23M	0.05%	$9.42M
Eam investors	250.79K	0.04%	$255.81K
Scientech research	79.81K	0.02%	$81.40K
Shelton wealth management	28.00K	0.01%	$28.56K
Point72 asia (singapore) pte.	51.20K	0.01%	$52.22K
Boothbay fund management	537.22K	0.01%	$547.96K
Schonfeld strategic advisors	1.71M	0.01%	$1.74M

Top Buyers

Holder	Shares	% Assets	Change
Jacobs levy equity management	2.95M	0.00%	2.76M
Point72 asset management	2.27M	0.01%	2.27M
Ikarian capital	1.86M	0.26%	1.86M
Schonfeld strategic advisors	1.71M	0.01%	1.71M
Blackrock funding, inc. /de	5.19M	0.00%	1.56M

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-14.06M
Wasatch advisors lp	9.23M	0.05%	-10.21M
Blackrock	4.70M	-	-8.57M
Acadian asset management	-	-	-4.56M
State street	519.22K	-	-2.23M

New Positions

Holder	Shares	% Assets	Change	Value
Point72 asset management	2.27M	0.01%	2.27M	$2.32M
Ikarian capital	1.86M	0.26%	1.86M	$1.90M
Acuta capital partners	740.00K	0.76%	740.00K	$754.80M
Squarepoint ops	710.36K	0.00%	710.36K	$724.57K
Boothbay fund management	537.22K	0.01%	537.22K	$547.96K

Sold Out

Holder	Change
Td waterhouse canada	-31.00
Gps wealth strategies group	-100.00
Srs capital advisors	-142.00
Capital performance advisors llp	-200.00
Umb bank, n.a.	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	132	18.92%	56,338,818	0.73%	27	3.75%	67	63.41%	31	-6.06%
Sep 30, 2024	111	-13.28%	55,928,091	-35.58%	26	1.16%	41	-28.07%	33	-23.26%
Jun 30, 2024	128	-3.03%	86,818,721	-14.00%	48	1.54%	57	7.55%	43	-12.24%
Mar 31, 2024	132	0.76%	100,948,720	16.17%	55	2.34%	53	-13.11%	49	13.95%
Dec 31, 2023	131	-2.96%	86,900,000	-15.17%	48	1.45%	61	41.86%	43	-12.24%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	5.99M	2.81%	-
Vanguard US Total Market Shares ETF	5.65M	2.51%	1.00
Wasatch Ultra Growth	4.53M	2.17%	-6.44M
SPDR® S&P Biotech ETF	3.73M	1.75%	-22.75K
Vanguard Institutional Extnd Mkt Idx Tr	3.07M	1.44%	-
Wasatch Micro Cap	2.34M	1.12%	-3.31M
Vanguard Strategic Small-Cap Equity Inv	1.71M	0.82%	-
Vanguard Explorer Inv	1.40M	0.67%	-
Fidelity Extended Market Index	1.04M	0.46%	-6.61K
Schwab US Small-Cap ETF™	888.62K	0.40%	3.25K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 26, 2023	BIOGEN INC.	-	Sell	$3.00M
Aug 29, 2022	BIOGEN INC.	-	Sell	$2.13M
Aug 30, 2022	BIOGEN INC.	-	Sell	$526.52K
Aug 29, 2022	Biogen MA Inc.		Sell	$526.52K
Aug 29, 2022	Biogen MA Inc.		Sell	$2.13M

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-

SGMO Ownership FAQ

Who Owns Sangamo Therapeutics?

Sangamo Therapeutics shareholders are primarily institutional investors at 27.04%, followed by 2.38% insiders and 70.58% retail investors. The average institutional ownership in Sangamo Therapeutics's industry, Biotech Stocks , is 68.48%, which Sangamo Therapeutics falls below.

Who owns the most shares of Sangamo Therapeutics?

Sangamo Therapeutics’s largest shareholders are Vanguard group (9.37M shares, 4.50%), Wasatch advisors lp (9.23M shares, 4.43%), and Blackrock (4.7M shares, 2.61%). Together, they hold 11.54% of Sangamo Therapeutics’s total shares outstanding.

Does Blackrock own Sangamo Therapeutics?

Yes, BlackRock owns 2.61% of Sangamo Therapeutics, totaling 4.7M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.69M$. In the last quarter, BlackRock decreased its holdings by -8.575M shares, a -64.58% change.

Who is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested?

Acuta capital partners is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.76% of its assets in 740K Sangamo Therapeutics shares, valued at 754.8M$.

Who is the top mutual fund holder of Sangamo Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Sangamo Therapeutics shares, with 2.81% of its total shares outstanding invested in 5.99M Sangamo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools